Player FM - Internet Radio Done Right
Checked 29d ago
Ajouté il y a huit ans
Contenu fourni par The Immune-Mediated Inflammatory Disease Forum. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par The Immune-Mediated Inflammatory Disease Forum ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !
Mettez-vous hors ligne avec l'application Player FM !
Discussing AxSpA Podcast: Efficacy and Safety of Upadacitinib
Manage episode 456390739 series 1044916
Contenu fourni par The Immune-Mediated Inflammatory Disease Forum. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par The Immune-Mediated Inflammatory Disease Forum ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar, and Xenfon Baraliakos to discuss a recent study on the efficacy and safety of upadacitinib in patient with ankylosing spondylitis.
…
continue reading
337 episodes
Manage episode 456390739 series 1044916
Contenu fourni par The Immune-Mediated Inflammatory Disease Forum. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par The Immune-Mediated Inflammatory Disease Forum ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar, and Xenfon Baraliakos to discuss a recent study on the efficacy and safety of upadacitinib in patient with ankylosing spondylitis.
…
continue reading
337 episodes
Tous les épisodes
×T
The IMID Forum
1 Discussing AxSpA Podcast: Efficacy and Safety of Upadacitinib 18:42
18:42
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:42Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, Atul Deodhar, and Xenfon Baraliakos to discuss a recent study on the efficacy and safety of upadacitinib in patient with ankylosing spondylitis.…
T
The IMID Forum
1 Discussing RA: Insights into Filgotinib and Tofacitinib in RA 24:13
24:13
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
24:13Join Professor Iain McInnes and Professor Rieke Alten for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in RA. In this episode, they discuss two papers which discuss the efficacy and safety of filgotinib, and lymphocyte count and infection risk associated with tofacitinib in rheumatoid arthritis.…
T
The IMID Forum
ACR 2024 Review Podcast by The Immune-Mediated Inflammatory Disease Forum
T
The IMID Forum
1 PsA Podcast: DISCOVER-2 and BE OPTIMAL/BE COMPLETE post-hoc analyses 30:53
30:53
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
30:53Join Professors Peter Nash and Philip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered a post hoc analysis examining the rapid and sustained efficacy of bimekizumab in PsA patients across different subgroups, focusing on improvements in pain, fatigue, and physical function over 16 weeks. The conversation also covered a long-term analysis of guselkumab assessing the durability of clinical improvements in joint and skin symptoms in PsA patients over a 2-year period.…
T
The IMID Forum
1 Discussing RA: Insights into Filgotinib and Tofacitinib in RA 19:16
19:16
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
19:16Join Professor Iain McInnes and Professor Johannes Bijlsma for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss two papers which discuss the efficacy and safety of filgotinib, and lymphocyte count and infection risk associated with tofacitinib in rheumatoid arthritis.…
T
The IMID Forum
1 Webinar Highlights Podcast: CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases 26:39
26:39
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
26:39Webinar Highlights Podcast: Join Professor Iain McInnes and Professor Georg Schett as they discuss the recent webinar hosted on the IMID Forum: “CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases”. Listen to them discuss key highlights from the webinar including the development of CAR T-cell therapy, the application of CAR T to autoimmune diseases, and the potential risks and reservations associated with this therapeutic approach.…
T
The IMID Forum
ACR 2024 Highlights: Day 3 by The Immune-Mediated Inflammatory Disease Forum
T
The IMID Forum
ACR 2024 Highlights: Day 2 by The Immune-Mediated Inflammatory Disease Forum
T
The IMID Forum
ACR 2024 Highlights: Day 1 by The Immune-Mediated Inflammatory Disease Forum
T
The IMID Forum
ACR 2024: Preview Podcast by The Immune-Mediated Inflammatory Disease Forum
T
The IMID Forum
1 AxSpA Podcast: Efficacy and Safety of IV secukinumab 23:30
23:30
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
23:30Join us for the latest axSpA podcast brought to you by the Immune-Mediated Inflammatory Disease Forum! This month, Dr Sofia Ramiro is joined by Professors Hideto Kameda, and Atul Deodhar to discuss a recent study on the efficacy and safety of IV secukinumab in patient with active axSpA.
T
The IMID Forum
1 Discussing RA: Navigating JAKis, TNFis, and the quest for optimal RA therapy 22:03
22:03
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
22:03Join Professor Iain McInnes and Professor Leonard Calabrese for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest information and data in RA. In this episode, they discuss two papers which investigate the efficacy and safety of JAK inhibitors and TNF inhibitors for rheumatoid arthritis, while also uncovering the best treatment strategies for difficult-to-treat RA.…
T
The IMID Forum
1 Author Interview: Derin Karacabeyli, 2024 33:27
33:27
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
33:27Join Professor Peter Nash from the Griffith University in Brisbane, and Dr Derin Karacabeyli of Arthritis Research Canada, a rheumatologist and resident in the University of British Columbia Clinician Investigator Program, as they discuss his recent paper ‘Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A population-based study’, published in PLoS One on 08th August 2024.…
T
The IMID Forum
1 Webinar Highlights Podcast 2: Evolving Therapeutic Strategies for Psoriatic Diseases 32:56
32:56
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
32:56Webinar Highlights Podcast: Join Professor Christopher Ritchlin, and Professor Philip Mease as they discuss the recent webinar hosted on the IMID Forum ‘Evolving Therapeutic Strategies for Psoriatic Diseases: Not all IL-23s are Created Similar - Part 2’. Watch them discuss key highlights from the webinar including the burden of PsA and PsO, the similarities and differences in pathology in skin and joints across psoriatic arthritis, and a special focus on IL-23, and its clinical data and impact across different tissue domains.…
T
The IMID Forum
1 PsA Podcast: Bimekizumab: Efficacy, safety, and effectiveness in PsA 21:04
21:04
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
21:04Join Professors Peter Nash, Philip Mease, and Laura Coates as they discuss the top publications in the world of PsA. This month, the conversation covered a matching-adjusted indirect comparison (MAIC) to assess the comparative efficacy of bimekizumab and risankizumab in patients with psoriatic arthritis over 52 weeks, and a post hoc analysis investigating the efficacy and safety of bimekizumab in PsA patients with or without concomitant methotrexate over 52 weeks.…
Bienvenue sur Lecteur FM!
Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.